Respiratory Syncytial Virus (RSV) - CARP

Respiratory Syncytial Virus (RSV) is a common seasonal respiratory illness that sometimes has devastating impacts for older adults.

Signs and symptoms: RSV impacts the lungs and breathing passages. While it can start out mild with slight congestion, sore throat, and/or fever, RSV can become a serious illness, leaving people breathless, coughing up mucus, and vulnerable to bacterial pneumonia.

Risk of severe impacts (hospitalization or even death): Adults age 60+ are at risk, as are those who are immunocompromised, have lung diseases like asthma or COPD, or who have underlying conditions like diabetes, congestive heart failure, or kidney disease.

Health Canada has recently approved a vaccine for adults aged 60 and older to help protect against lower lung disease caused by Respiratory Syncytial Virus (RSV).

However, the RSV vaccine  is not yet funded by the government 

With provincial budget discussions for next year underway, we are asking for your help in telling the government that we expect public funding of an RSV immunization program for all seniors across Canada.

Supported by educational grants from :